Literature DB >> 19531156

Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.

A Hanna1, P Horne, D Yager, C Eckman, E Eckman, C Janus.   

Abstract

The relationship between amyloid beta and cognitive dysfunction in mouse models of Alzheimer's disease has been evaluated predominantly with the spatial reference memory version of the water maze task. However, as Alzheimer's disease encompasses decline in multiple memory systems, it is important to also utilize non-spatial tasks to fully characterize the role of amyloid on behaviour in animal models. We used the TgCRND8 mouse model of Alzheimer's disease to evaluate the effect of amyloid on spatial reference memory, as well as on the non-spatial task of acquisition of conditioned taste aversion, and on the procedural task of swimming to a visible platform. We demonstrate that 8- to 12-month-old TgCRND8 mice are significantly impaired in all three tasks, and that the levels of soluble amyloid beta are significantly correlated with impairment in spatial reference memory, but not with impairment in conditioned taste aversion or swimming to a visible platform. Insoluble fractions of amyloid, which correspond closely to amyloid plaque burden in the brain, are not associated with any behavioural measure. Our study extends the characterization of the model to stages of advanced amyloid pathology and demonstrates that older TgCRND8 mice are impaired in multiple memory systems, including procedural tasks, which are spared at younger ages. The lack of association between amyloid plaques and memory decline supports clinical findings in Alzheimer's patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531156     DOI: 10.1111/j.1601-183X.2009.00510.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  10 in total

1.  Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

Authors:  Beverly M Francis; John Kim; Meredith E Barakat; Stephan Fraenkl; Yeni H Yücel; Shiyong Peng; Bernadeta Michalski; Margaret Fahnestock; Joanne McLaurin; Howard T J Mount
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

2.  Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Panaiyur S Mohan; Susmita Kaushik; Asok Kumar; Masuo Ohno; Stephen D Schmidt; Daniel Wesson; Urmi Bandyopadhyay; Ying Jiang; Monika Pawlik; Corrinne M Peterhoff; Austin J Yang; Donald A Wilson; Peter St George-Hyslop; David Westaway; Paul M Mathews; Efrat Levy; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

3.  A nonhuman primate model of Alzheimer's disease generated by intracranial injection of amyloid-β42 and thiorphan.

Authors:  Wende Li; Yu'e Wu; Fangui Min; Zhuo Li; Jiayuan Huang; Ren Huang
Journal:  Metab Brain Dis       Date:  2010-09-14       Impact factor: 3.584

4.  Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis.

Authors:  Amanda Hanna; Kayleigh Iremonger; Pritam Das; Dennis Dickson; Todd Golde; Christopher Janus
Journal:  Alzheimers Res Ther       Date:  2012-06-14       Impact factor: 6.982

Review 5.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models.

Authors:  Scott J Webster; Adam D Bachstetter; Peter T Nelson; Frederick A Schmitt; Linda J Van Eldik
Journal:  Front Genet       Date:  2014-04-23       Impact factor: 4.599

6.  Time course of focused ultrasound effects on β-amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Charissa T Poon; Kairavi Shah; Chiungting Lin; Ryan Tse; Kate K Kim; Skyler Mooney; Isabelle Aubert; Bojana Stefanovic; Kullervo Hynynen
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

7.  Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.

Authors:  Kristiana Xhima; Kelly Markham-Coultes; Rikke Hahn Kofoed; H Uri Saragovi; Kullervo Hynynen; Isabelle Aubert
Journal:  Brain       Date:  2022-08-27       Impact factor: 15.255

8.  Normal cognition in transgenic BRI2-Aβ mice.

Authors:  Jungsu Kim; Paramita Chakrabarty; Amanda Hanna; Amelia March; Dennis W Dickson; David R Borchelt; Todd Golde; Christopher Janus
Journal:  Mol Neurodegener       Date:  2013-05-12       Impact factor: 14.195

9.  Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease.

Authors:  Scott J Webster; Adam D Bachstetter; Linda J Van Eldik
Journal:  Alzheimers Res Ther       Date:  2013-05-24       Impact factor: 6.982

10.  Effects of Aged Garlic Extract on Cholinergic, Glutamatergic and GABAergic Systems with Regard to Cognitive Impairment in Aβ-Induced Rats.

Authors:  Piyaporn Thorajak; Wanassanun Pannangrong; Jariya Umka Welbat; Wunnee Chaijaroonkhanarak; Kittisak Sripanidkulchai; Bungorn Sripanidkulchai
Journal:  Nutrients       Date:  2017-07-01       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.